High materiality8/10
Scribe Therapeutics initiated with an Overweight at Wells Fargo
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Wells Fargo initiates SCTX with an Overweight and a target of $60; current price $21.19. Price since signal up 27.94.
Target: $60
Posted price: $21.19
Analyst firm: Wells Fargo
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.